Author:
Lindauer Markus,Hochhaus Andreas
Publisher
Springer Berlin Heidelberg
Reference162 articles.
1. Algazi AP, Weber JS, Andrews SC (2012) Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. Br J Cancer 106:85–91
2. Amrein L, Hernandez TA, Ferrario C et al (2008) Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabine in vitro. Br J Haematol 143:698–706
3. Amrein PC, Attar EC, Takvorian T et al (2011) Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia. Clin Cancer Res 17:2977–2986
4. Apperley JF, Cortes JE, Kim DW et al (2009) Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial. J Clin Oncol 27:3472–3479
5. Araujo J, Armstrong AJ, Braud EL et al (2009) Dasatinib and docetaxel combination treatment for patients with castration-resistant progressive prostate cancer: a phase I/II study (CA180086). J Clin Oncol 27(Suppl):5061
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献